Compounded TB-500 (Thymosin Beta-4) in New Mexico
Check whether compounded TB-500 (Thymosin Beta-4) can be routed, what restrictions may apply, and what to ask your prescriber or pharmacist.
Read the compounded TB-500 (Thymosin Beta-4) background guide →About Compounded TB-500 (Thymosin Beta-4) in New Mexico
Important: TB-500 (Thymosin Beta-4) is not currently eligible for compounding by licensed U.S. pharmacies due to FDA restrictions. Quote requests for TB-500 cannot be fulfilled through Compounding Finder.
Key Questions About TB-500 (Thymosin Beta-4)
Can I get TB-500 (Thymosin Beta-4) compounded?
Not through Compounding Finder right now. A prescriber and pharmacist still have to decide whether any compounded TB-500 (Thymosin Beta-4) preparation is legally and clinically appropriate.
Will Compounding Finder send my TB-500 (Thymosin Beta-4) request to pharmacies?
No. Compounding Finder is not sending TB-500 (Thymosin Beta-4) quote requests to pharmacies at this time, so we cannot return TB-500 (Thymosin Beta-4) quotes or prices. If FDA guidance changes, we will revisit.
Source notes: FDA explains that compounded drugs are not FDA-approved finished products and describes 503A compounding around patient-specific prescriptions. See Compounding and the FDA and Section 503A.
Related Medications in New Mexico
- BPC-157 in New Mexico
- GHK-Cu (Copper Peptide) in New Mexico
- Thymosin Alpha-1 in New Mexico
- LL-37 in New Mexico
- VIP (Vasoactive Intestinal Peptide) in New Mexico
- 5-Fluorouracil (Topical) in New Mexico
- Alpha Lipoic Acid (ALA) Injectable in New Mexico
- Amitriptyline (Topical) in New Mexico
- Amlexanox in New Mexico
- Amoxicillin-Clavulanate Flavored Suspension (Veterinary) in New Mexico
- Anastrozole in New Mexico
- AOD-9604 in New Mexico
TB-500 (Thymosin Beta-4) by City in New Mexico
Learn more: Compounded TB-500 (Thymosin Beta-4) — Overview →
Browse all: View All Compounded Medications →
We Do Not Currently Route TB-500 (Thymosin Beta-4) Quote Requests
TB-500 is not on the FDA 503A bulk drug substances list. An FDA advisory committee voted in July 2026 to recommend adding it, but FDA has not acted, so US compounding pharmacies have no clear legal pathway to prepare it and Compounding Finder is not sending TB-500 quote requests to pharmacies. If FDA guidance changes, we will revisit.